Abstract
Nociplastic pain (NP), as a mechanistic term, denotes pain arising from altered nociception without clear evidence of tissue or somatosensory damage. Fibromyalgia (FM), a prototypical NP condition, incorporates a broad continuum of phenotypes with a distinct neurobiological signature and shared NP attributes. The nociplastic concept may provide a new opportunity for early diagnosis of FM by identifying the characteristic NP features before a state of pain generalization and symptoms clustering. In this approach, even individual symptoms associated with NP features are worthy of attention to denote FM. It may provide a timely diagnosis of FM before clinical progression to a severe and hard-to-manage condition. Furthermore, collecting all various FM phenotypes under the nociplastic concept and not delimiting FM to the only typical presentation allows investigators to identify FM subgroups reflecting potentially distinct pathophysiologic mechanisms and biomarkers. This viewpoint can be served in future studies to develop individualized management. In this review, we postulate a novel approach to early FM diagnosis and management based on NP conceptualization and phenotype recognition.
Key Points • FM as a NP condition represents overlapping clinical phenotypes and incomplete presentations especially in early stage of illness. • The mechanistic approach based on the NP features of FM can be implicated in the timely diagnosis and management of FM. • The NP-based approach to FM provides a broader viewpoint beyond FM delimitation to pain generalization and polysymptomatic complaints. |
Similar content being viewed by others
References
Kosek E, Cohen M, Baron R, Gebhart GF, Mico JA, Rice ASC et al (2016) Do we need a third mechanistic descriptor for chronic pain states? Pain 157(7):1382–1386
Trouvin AP, Perrot S (2019) New concepts of pain. Best Pract Res Clin Rheumatol 33(3):101415
Fitzcharles MA, Cohen SP, Clauw DJ, Littlejohn G, Usui C, Häuser W (2021) Nociplastic pain: towards an understanding of prevalent pain conditions. Lancet 397(10289):2098–2110
Kosek E, Clauw D, Nijs J, Baron R, Gilron I, Harris RE et al (2021) Chronic nociplastic pain affecting the musculoskeletal system: clinical criteria and grading system. Pain 162(11):2629–2634
Bidari A, Ghavidel Parsa B, Ghalehbaghi B (2018) Challenges in fibromyalgia diagnosis: from meaning of symptoms to fibromyalgia labeling. The Korean journal of pain 31(3):147–154
Häuser W, Sarzi-Puttini P, Fitzcharles MA (2019) Fibromyalgia syndrome: under-over- and misdiagnosis. Clin Exp Rheumatol 37(Suppl 116(1)):90–7
Häuser W, Fitzcharles M-A (2018) Facts and myths pertaining to fibromyalgia. Dialogues Clin Neurosci 20(1):53–62
Maixner W, Fillingim RB, Williams DA, Smith SB, Slade GD (2016) Overlapping chronic pain conditions: implications for diagnosis and classification. J Pain 17(9 Suppl):T93-t107
Sarzi-Puttini P, Giorgi V, Marotto D, Atzeni F (2020) Fibromyalgia: an update on clinical characteristics, aetiopathogenesis and treatment. Nat Rev Rheumatol 16(11):645–660
Ghavidel-Parsa B, Bidari A, Tohidi S, Shenavar I, Kazemnezhad Leyli E, Hosseini K et al (2021) Implication of invalidation concept in fibromyalgia diagnosis. Clin Rheumatol 40(6):2369–2376
Sluka KA, Clauw DJ (2016) Neurobiology of fibromyalgia and chronic widespread pain. Neuroscience 338:114–129
Clauw D (2021) Time to stop the fibromyalgia criteria wars and refocus on identifying and treating individuals with this type of pain earlier in their illness. Arthritis Care Res (Hoboken) 73(5):613–616
Arnold LM, Bennett RM, Crofford LJ, Dean LE, Clauw DJ, Goldenberg DL et al (2019) AAPT diagnostic criteria for fibromyalgia. J Pain 20(6):611–628
Wolfe F, Walitt B (2013) Culture, science and the changing nature of fibromyalgia. Nat Rev Rheumatol 9(12):751–755
Ghavidel-Parsa B, Bidari A (2021) Two sides on the fibromyalgia coin: physical pain and social pain (invalidation). Clin Rheumatol 40(3):841–848
Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL et al (1990) The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 33(2):160–72
Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P et al (2010) The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken) 62(5):600–610
Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Häuser W, Katz RS et al (2011) Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia. J Rheumatol 38(6):1113–1122
Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Häuser W, Katz RL et al (2016) 2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria. Semin Arthritis Rheum 46(3):319–329
Habib G, Sakas F, Khazin F (2021) Initial presentation of pain in patients with fibromyalgia. Isr Med Assoc J 23(9):576–579
Harte SE, Harris RE, Clauw DJ (2018) The neurobiology of central sensitization. J Appl Biobehav Res 23(2):e12137
Kindler LL, Jones KD, Perrin N, Bennett RM (2010) Risk factors predicting the development of widespread pain from chronic back or neck pain. J Pain 11(12):1320–1328
Choy E, Perrot S, Leon T, Kaplan J, Petersel D, Ginovker A et al (2010) A patient survey of the impact of fibromyalgia and the journey to diagnosis. BMC Health Serv Res 10(1):102
Kool MB, van Middendorp H, Boeije HR, Geenen R (2009) Understanding the lack of understanding: invalidation from the perspective of the patient with fibromyalgia. Arthritis Rheum 61(12):1650–1656
Santiago MG, Marques A, Kool M, Geenen R, da Silva JAP (2017) Invalidation in patients with rheumatic diseases: clinical and psychological framework. J Rheumatol 44(4):512–518
Homma M, Ishikawa H, Kiuchi T (2018) Illness perceptions and negative responses from medical professionals in patients with fibromyalgia: association with patient satisfaction and number of hospital visits. Patient Educ Couns 101(3):532–540
Ghavidel-Parsa B, Bidari A, Amir Maafi A, Ghalebaghi B (2015) The iceberg nature of fibromyalgia burden: the clinical and economic aspects. Korean J Pain 28(3):169–176
Duque L, Fricchione G (2019) Fibromyalgia and its new lessons for neuropsychiatry. Med Sci Monit Basic Res 25:169–178
Ghavidel-Parsa B, Bidari A, Atrkarroushan Z, Khosousi MJ (2021) Implication of the nociplastic features for clinical diagnosis of fibromyalgia: development of the preliminary nociplastic-based fibromyalgia features (NFF) tool. ACR Open Rheumatol
Häuser W, Perrot S, Clauw DJ, Fitzcharles MA (2018) Unravelling fibromyalgia-steps toward individualized management. J Pain 19(2):125–134
Häuser W, Ablin J, Fitzcharles MA, Littlejohn G, Luciano JV, Usui C et al (2015) Fibromyalgia Nat Rev Dis Primers 1:15022
Bidari A, Ghavidel-Parsa B, Ghalehbaghi B (2009) Reliability of ACR criteria over time to differentiate classic fibromyalgia from nonspecific widespread pain syndrome: a 6-month prospective cohort study. Mod Rheumatol 19(6):663–669
Walitt B, Katz RS, Bergman MJ, Wolfe F (2016) Three-quarters of persons in the US population reporting a clinical diagnosis of fibromyalgia do not satisfy fibromyalgia criteria: the 2012 National Health Interview Survey. PLoS ONE 11(6):e0157235
Walitt B, Nahin RL, Katz RS, Bergman MJ, Wolfe F (2015) The prevalence and characteristics of fibromyalgia in the 2012 National Health Interview Survey. PLoS ONE 10(9):e0138024
Wolfe F, Brähler E, Hinz A, Häuser W (2013) Fibromyalgia prevalence, somatic symptom reporting, and the dimensionality of polysymptomatic distress: results from a survey of the general population. Arthritis Care Res (Hoboken) 65(5):777–785
Vincent A, Hoskin TL, Whipple MO, Clauw DJ, Barton DL, Benzo RP et al (2014) OMERACT-based fibromyalgia symptom subgroups: an exploratory cluster analysis. Arthritis Res Ther 16(5):463
Seifert O, Baerwald C (2019) Impact of fatigue on rheumatic diseases. Best Pract Res Clin Rheumatol 33(3):101435
Apkarian AV, Baliki MN, Geha PY (2009) Towards a theory of chronic pain. Prog Neurobiol 87(2):81–97
Flor H, Birbaumer N, Turk DC (1990) The psychobiology of chronic pain. Adv Behav Res Ther 12(2):47–84
Diers M (2019) Neuroimaging the pain network - implications for treatment. Best Pract Res Clin Rheumatol 33(3):101418
Wallrath MK, Rubel J, Ohls I, Demiralay C, Hechler T (2020) Bottom-up or top-down?: the role of child and parent chronic pain and anxiety in the context of parental catastrophizing and solicitousness. Eur J Pain 24(3):604–616
Villemure C, Bushnell CM (2002) Cognitive modulation of pain: how do attention and emotion influence pain processing? PAIN 95(3):195–199
Williams ACC, Craig KD (2016) Updating the definition of pain. Pain 157(11):2420–2423
Ellingson LD, Stegner AJ, Schwabacher IJ, Lindheimer JB, Cook DB (2018) Catastrophizing interferes with cognitive modulation of pain in women with fibromyalgia. Pain Med 19(12):2408–2422
Sancassiani F, Machado S, Ruggiero V, Cacace E, Carmassi C, Gesi C et al (2017) The management of fibromyalgia from a psychosomatic perspective: an overview. Int Rev Psychiatry 29(5):473–488
Mayer TG, Neblett R, Cohen H, Howard KJ, Choi YH, Williams MJ et al (2012) The development and psychometric validation of the central sensitization inventory. Pain Pract 12(4):276–285
Perrot S, Bouhassira D, Fermanian J (2010) Development and validation of the Fibromyalgia Rapid Screening Tool (FiRST). Pain 150(2):250–256
Bennett RM, Friend R, Marcus D, Bernstein C, Han BK, Yachoui R et al (2014) Criteria for the diagnosis of fibromyalgia: validation of the modified 2010 preliminary American College of Rheumatology criteria and the development of alternative criteria. Arthritis Care Res (Hoboken) 66(9):1364–1373
Yunus MB (2008) Central sensitivity syndromes: a new paradigm and group nosology for fibromyalgia and overlapping conditions, and the related issue of disease versus illness. Semin Arthritis Rheum 37(6):339–352
Grayston R, Czanner G, Elhadd K, Goebel A, Frank B, Üçeyler N et al (2019) A systematic review and meta-analysis of the prevalence of small fiber pathology in fibromyalgia: implications for a new paradigm in fibromyalgia etiopathogenesis. Semin Arthritis Rheum 48(5):933–940
Egloff N, von Känel R, Müller V, Egle UT, Kokinogenis G, Lederbogen S et al (2015) Implications of proposed fibromyalgia criteria across other functional pain syndromes. Scand J Rheumatol 44(5):416–424
Kia S, Choy E (2017) Update on treatment guideline in fibromyalgia syndrome with focus on pharmacology. Biomedicines 5(2):20
Tzadok R, Ablin JN (2020) Current and emerging pharmacotherapy for fibromyalgia. Pain Res Manage 2020:6541798
López-Solà M, Woo C-W, Pujol J, Deus J, Harrison BJ, Monfort J et al (2017) Towards a neurophysiological signature for fibromyalgia. Pain 158(1):34–47
Gracely RH, Petzke F, Wolf JM, Clauw DJ (2002) Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia. Arthritis Rheum 46(5):1333–1343
Giesecke T, Gracely RH, Grant MA, Nachemson A, Petzke F, Williams DA et al (2004) Evidence of augmented central pain processing in idiopathic chronic low back pain. Arthritis Rheum 50(2):613–623
Naliboff BD, Derbyshire SW, Munakata J, Berman S, Mandelkern M, Chang L et al (2001) Cerebral activation in patients with irritable bowel syndrome and control subjects during rectosigmoid stimulation. Psychosom Med 63(3):365–375
Napadow V, LaCount L, Park K, As-Sanie S, Clauw DJ, Harris RE (2010) Intrinsic brain connectivity in fibromyalgia is associated with chronic pain intensity. Arthritis Rheum 62(8):2545–2555
Seminowicz DA, Davis KD (2007) Pain enhances functional connectivity of a brain network evoked by performance of a cognitive task. J Neurophysiol 97(5):3651–3659
Apkarian AV, Sosa Y, Sonty S, Levy RM, Harden RN, Parrish TB et al (2004) Chronic back pain is associated with decreased prefrontal and thalamic gray matter density. J Neurosci 24(46):10410–10415
Smallwood RF, Laird AR, Ramage AE, Parkinson AL, Lewis J, Clauw DJ et al (2013) Structural brain anomalies and chronic pain: a quantitative meta-analysis of gray matter volume. J Pain 14(7):663–675
Lutz J, Jäger L, de Quervain D, Krauseneck T, Padberg F, Wichnalek M et al (2008) White and gray matter abnormalities in the brain of patients with fibromyalgia: a diffusion-tensor and volumetric imaging study. Arthritis Rheum 58(12):3960–3969
O’Mahony LF, Srivastava A, Mehta P, Ciurtin C (2021) Is fibromyalgia associated with a unique cytokine profile? A systematic review and meta-analysis Rheumatology (Oxford) 60(6):2602–2614
Theoharides TC, Tsilioni I, Bawazeer M (2019) Mast Cells, Neuroinflammation and pain in fibromyalgia syndrome. Front Cell Neurosci 13
Albrecht DS, Forsberg A, Sandström A, Bergan C, Kadetoff D, Protsenko E et al (2019) Brain glial activation in fibromyalgia - a multi-site positron emission tomography investigation. Brain Behav Immun 75:72–83
Shraim MA, Massé-Alarie H, Hodges PW (2021) Methods to discriminate between mechanism-based categories of pain experienced in the musculoskeletal system: a systematic review. Pain 162(4):1007–1037
Nijs J, George SZ, Clauw DJ, Fernández-de-las-Peñas C, Kosek E, Ickmans K et al (2021) Central sensitisation in chronic pain conditions: latest discoveries and their potential for precision medicine. The Lancet Rheumatology 3(5):e383–e392
López-Ruiz M, Losilla JM, Monfort J, Portell M, Gutiérrez T, Poca V et al (2019) Central sensitization in knee osteoarthritis and fibromyalgia: beyond depression and anxiety. PloS one 14(12):e0225836-e
Cohen SP, Vase L, Hooten WM (2021) Chronic pain: an update on burden, best practices, and new advances. Lancet 397(10289):2082–2097
Finnerup NB, Haroutounian S, Kamerman P, Baron R, Bennett DLH, Bouhassira D et al (2016) Neuropathic pain: an updated grading system for research and clinical practice. Pain 157(8):1599–1606
Ghavidel-Parsa B, Bidari A, Rahimi A, Gharibpoor F, Khosousi MJ (2021) No effect of approved fibromyalgia drugs on the social pain (invalidation) contrary to physical pain: an open-label short-term randomized clinical trial. Clin Rheumatol
Häuser W, Jones G (2019) Psychological therapies for chronic widespread pain and fibromyalgia syndrome. Best Pract Res Clin Rheumatol 33(3):101416
Ryabkova VA, Churilov LP, Shoenfeld Y (2019) Neuroimmunology: what role for autoimmunity, neuroinflammation, and small fiber neuropathy in fibromyalgia, chronic fatigue syndrome, and adverse events after human papillomavirus vaccination? Int J Mol Sci 20(20)
Malfliet A, Kregel J, Meeus M, Danneels L, Cagnie B, Roussel N et al (2018) Patients with chronic spinal pain benefit from pain neuroscience education regardless the self-reported signs of central sensitization: secondary analysis of a randomized controlled multicenter trial. Pm r 10(12):1330–43.e1
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
None.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Bidari, A., Ghavidel-Parsa, B. Nociplastic pain concept, a mechanistic basis for pragmatic approach to fibromyalgia. Clin Rheumatol 41, 2939–2947 (2022). https://doi.org/10.1007/s10067-022-06229-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-022-06229-5